Simplify Logo

Full-Time

Medical Science Liaison

Northeast

Posted on 8/20/2024

Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

501-1,000 employees

Develops therapies for neurological disorders

Biotechnology
Healthcare

Senior

Remote in USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Sales
Communications
Marketing
PowerPoint/Keynote/Slides
Requirements
  • PharmD or PhD in a related field required.
  • Targeting 5 years progressively responsible experience in the biopharmaceutical industry and/or similar clinical/research environment, including 3 years as an MSL.
  • Expert scientific and pharmaceutical knowledge.
  • Knowledge of regulatory, compliance, commercial, and clinical issues affecting the pharmaceutical and managed care industries.
  • Knowledge of customer segments and market dynamics.
  • Excellent planning and organizational skills.
  • Highly developed interpersonal skills.
  • Ability to work independently and with cross-functional teams.
  • Excellent oral and written communication skills, including presentation and facilitation skills.
  • Demonstrated expertise in drug information.
  • High level of facility with relevant computer and software capabilities, including MS Office programs (e.g., Outlook, Word, Excel, and PowerPoint).
  • Ability to travel up to 75% of time, with primary residence within the geographical area or near a major airport.
Responsibilities
  • Identifies and develops relationships with national and regional medical and scientific thought leaders, patient advocacy groups, and centers of excellence consistent with the strategy and objectives of Acadia’s Medical Affairs and Development Departments.
  • Engages national and regional thought leaders to align interests, discuss research and medical information, and participate in scientific exchange and education about current and emerging therapies.
  • Provides Phase 2 / 3b / 4 research trial site support and investigator-initiated research proposal cultivation.
  • Develops and maintains scientific, clinical and therapeutic expertise for Acadia’s rare disease portfolio: including Rett Syndrome and Prader Willi Syndrome; therapies utilized to manage these diseases; trofinetide and carbetocin.
  • Cross-functionally collaborates, following all compliance guidelines, with regional field leadership partners including, HEOR-Field MSLs, Marketing regional business leaders (RBLs), Account Business Managers (ABMs), and Thought Leader Liaisons (TLLs).
  • Provides field strategic insights.
  • Identifies disease concepts and compound characteristics that can be leveraged into product development.
  • Provides appropriate scientific, clinical, and educational support for internal and external stakeholders.
  • Represents the company at specific continuing educational events, programs, medical meetings and conferences.
  • Supports Commercial operations by participating in Speaker and Sales Representative training.
  • Partners with the internal departments to ensure accurate delivery of medical and scientific information.
  • Other duties as assigned.
Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

View

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. Their products are created through extensive research and development, followed by rigorous clinical trials to ensure safety and effectiveness. Once approved by regulatory bodies like the FDA, these therapies are marketed to patients and healthcare providers. Acadia stands out from competitors by concentrating on areas with significant unmet medical needs and fostering strategic partnerships to enhance their research and market presence. The company's goal is to improve the quality of life for individuals with neurological conditions through effective treatments.

Company Stage

IPO

Total Funding

$813.4M

Headquarters

Dallas, Texas

Founded

1993

Simplify Jobs

Simplify's Take

What believers are saying

  • Acadia's launch of Magnolia's Guide to Adventuring showcases their innovative approach to raising disease awareness and redefining perceptions of Rett syndrome.
  • The acceptance of trofinetide for priority review by Health Canada could lead to significant market expansion and first-mover advantage in treating Rett syndrome in Canada.
  • The appointment of Dr. Elizabeth H. Z. Thompson as Executive Vice President, Head of Research and Development, signals a strong commitment to advancing their R&D capabilities.

What critics are saying

  • The failure of the Phase III ADVANCE-2 trial for pimavanserin in schizophrenia highlights the high-risk nature of drug development in the biopharmaceutical sector.
  • Dependence on regulatory approvals, such as the FDA and Health Canada, introduces uncertainty and potential delays in bringing therapies to market.

What makes Acadia Pharmaceuticals Inc. unique

  • Acadia Pharmaceuticals focuses exclusively on neurological disorders, setting it apart from competitors with broader therapeutic areas.
  • Their commitment to corporate social responsibility, including initiatives like the Rett Sibling Scholarship, enhances their reputation and community engagement.
  • Acadia's strategic partnerships and corporate sponsorships amplify their research capabilities and market reach, distinguishing them from competitors who may not leverage such collaborations.
INACTIVE